The global war on terror has cost the U.S. $437 billion since September 11, the Congressional Research Service estimated last month, including $319 billion for the war in Iraq. (The Pentagon claims the latter figure should be $210 billion.)
The CRS cost estimate has been widely reported, but the underlying report has not been widely available to the public. Now it is:
“The Cost of Iraq, Afghanistan, and Other Global War on Terror Operations Since 9/11” (pdf), updated June 14, 2006.
Some other notable CRS reports obtained by Secrecy News include the following.
“Military Operations: Precedents for Funding Contingency Operations in Regular or in Supplemental Appropriations Bills” (pdf), June 13, 2006.
“Defense Procurement: Full Funding Policy — Background, Issues, and Options for Congress” (pdf), updated June 20, 2006.
“U.S. Democracy Promotion Policy in the Middle East: The Islamist Dilemma” (pdf), June 15, 2006.
“Freedom of Speech and Press: Exceptions to the First Amendment” (pdf), updated June 2, 2006.
Given the unreliability of private market funding for agricultural biotechnology R&D, substantial federal funding through research programs such as AgARDA is vital for accelerating R&D.
“Given the number of existential crises we must collectively confront, I have found policy entrepreneurship to be a fruitful avenue towards doing some of that work.”
We sit on the verge of another Presidential election – an opportunity for meaningful, science-based policy innovations that can appeal to lawmakers on both sides of the aisle.
Outdated Bureau of Labor Statistics classifications hampers the federal government’s ability to design and implement effective policies for emerging technologies sectors.